Pyrotinib Uses, Dosage, Side Effects and more
Pyrotinib is under investigation in clinical trial NCT03756064 (Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer).
| Trade Name | Pyrotinib |
| Generic | Pyrotinib |
| Type | |
| Formula | C32H31ClN6O3 |
| Weight | Average: 583.09 Monoisotopic: 582.2146166 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
